This project focuses on how germ cells control the function of Sertoli cells.

This study aims to identify and understand mechanisms of intrinsic and acquired resistance to RNA Polymerase I (Pol I) inhibition in cancer, with the goal of developing strategies to overcome resistance to Pol I inhibitors.

This study explores how dynamic changes in ribosomal DNA (rDNA) chromatin contribute to cancer development, aiming to uncover mechanisms of malignant transformation and potential therapeutic targets.

This project focuses on the role of H2A.B in spermatogenesis under heat stress.

This study aims to develop effective combination therapies using RNA Polymerase I (Pol I) inhibitors to enhance therapeutic efficacy and combat resistance in cancer treatment through synergistic effects with other drugs or treatments.

This project focuses on understanding the role of WNT in congenital heart defects.

This study evaluates UBF (Upstream Binding Factor) as a potential target for cancer therapy by investigating its role in cancer cell growth and survival.

This project uses next generation sequencing (NGS) and mass spectrometry to investigate the possible existence of regulatory interactions between ribonucleic acids, enzymes and metabolites to connect gene expression and metabolism

This project focuses the role of H2A.B in Hodgkin Lymphoma.

This study identifies new cancer therapeutic targets within the RNA Polymerase I-specific transcription factor network to uncover potential innovative treatments.

This study identifies ribosomal DNA sequence variations and analyzes their functional consequences.

This study seeks to identify biomarkers predicting sensitivity to RNA Polymerase I (Pol I) inhibition to enhance patient stratification and treatment outcomes in cancer therapy.

This project focuses on Cancer/Testis (C/T) antigens and their function.

This project focuses on the role of the histone variant H2A.B3 on spermatogenesis.

Investigating the role of Spindle-E Zinc Finger motif in piRNA ping-pong biogenesis